Therapeutic potential of “glycoengineering" in autoimmune disease. Alter glycoforms of endogenous IgG -> reduce pathogenic impact of antibodies. Cell paper by Pagan JD et al https://t.co/UbBsE1jV4L Year in review basic science #ACR18 @RheumNow